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ABSTRACT
Porcine reproductive and respiratory syndrome virus (PRRSV) nonstructural protein 1 (nsp1) is a multifunctional viral pro-
tein, which is involved in suppressing the host innate immune response and activating a unique2/1 programmed ribosomal
frameshifting (PRF) signal for the expression of frameshifting products. In this study, site-directed mutagenesis analysis showed
that the R128A or R129A mutation introduced into a highly conserved motif (123GKYLQRRLQ131) reduced the ability of nsp1
to suppress interferon beta (IFN-) activation and also impaired nsp1’s function as a PRF transactivator. Three recombinant
viruses, vR128A, vR129A, and vRR129AA, carrying single or double mutations in the GKYLQRRLQ motif were characterized. In
comparison to the wild-type (WT) virus, vR128A and vR129A showed slightly reduced growth abilities, while the vRR129AA mu-
tant had a significantly reduced growth ability in infected cells. Consistent with the attenuated growth phenotype in vitro, pigs
infected with nsp1mutants had lower levels of viremia than did WT virus-infected pigs. Compared to the WT virus in infected
cells, all three mutated viruses stimulated high levels of IFN- expression and exhibited a reduced ability to suppress the mRNA
expression of selected interferon-stimulated genes (ISGs). In pigs infected with nsp1mutants, IFN- production was increased
in the lungs at early time points postinfection, which was correlated with increased innate NK cell function. Furthermore, the
augmented innate response was consistent with the increased production of IFN- in pigs infected with mutated viruses. These
data demonstrate that residues R128 and R129 are critical for nsp1 function and that modifying these key residues in the GKYL
QRRLQ motif attenuates virus growth ability and improves the innate and adaptive immune responses in infected animals.
IMPORTANCE
PRRSV infection induces poor antiviral innate IFN and cytokine responses, which results in weak adaptive immunity. One of the
strategies in next-generation vaccine construction is to manipulate viral proteins/genetic elements involved in antagonizing the
host immune response. PRRSV nsp1was identified to be a strong innate immune antagonist. In this study, two basic amino
acids, R128 and R129, in a highly conserved GKYLQRRLQ motif were determined to be critical for nsp1 function. Mutations
introduced into these two residues attenuated virus growth and improved the innate and adaptive immune responses of infected
animals. Technologies developed in this study could be broadly applied to current commercial PRRSV modified live-virus
(MLV) vaccines and other candidate vaccines.
Porcine reproductive and respiratory syndrome (PRRS), a dis-ease described in the United States in 1987 (1) and in Europe
in 1990 (2), has caused tremendous economic losses to the swine
industry since its appearance. Hallmark symptoms of PRRS are
mild to severe respiratory disease in infected newborn and grow-
ing pigs and reproductive failure in pregnant sows. The etiologic
agent, PRRS virus (PRRSV), was first discovered in The Nether-
lands in 1991 (2). In the United States, PRRSV was first isolated
and characterized in 1992 (3, 4). Generally, infection of pigs by
most PRRSV strains dampens the host innate immune response
(5, 6). This initial suppression of the host innate immune response
leads to the delayed induction of protective cellular and humoral
immunity (7, 8), which provides a window of time that allows
PRRSV to replicate, be shed, and be transmitted to other contact-
naive animals. Therefore, strategies for vaccine development are
directed at constructing a PRRS vaccine capable of inducing high
levels of innate and adaptive immune responses.
PRRSV is an enveloped, positive-stranded RNA virus that be-
longs to the orderNidovirales, familyArteriviridae, which includes
equine arteritis virus (EAV),mouse lactate dehydrogenase-elevat-
ing virus (LDV), simian hemorrhagic fever virus (SHFV), and
several recently discoveredmonkey arteriviruses that are only dis-
tantly related to SHFV (9). The PRRSV genome is 15 kb in
length and contains at least 11 open reading frames (ORFs). The 3=
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end of the genome encodes four membrane-associated glycopro-
teins (GP2a, GP3, GP4, and GP5), three unglycosylated mem-
brane proteins (E, ORF5a, and M), and a nucleocapsid protein
(N) (10–19). The replicase-associated ORF1a and ORF1b genes
are situated at the 5= end and represent nearly 75% of the viral
genome. ORF1a and ORF1b encode two large polyproteins, pp1a
and pp1ab, with the expression of the latter depending on a 1
ribosomal frameshifting signal in the ORF1a/ORF1b overlap re-
gion. Following their synthesis from the genomic mRNA tem-
plate, the pp1a and pp1ab replicase polyproteins are processed
into at least 14 nonstructural proteins by a complex proteolytic
cascade that is directed by four proteinase domains encoded in
ORF1a, which include two papain-like proteinases (PLP1 and
PLP1) located in nsp1 and nsp1, a papain-like proteinase
(PLP2) domain located at the N terminus of nsp2, and a serine
proteinase located in nsp4. PLP1 autocleaves between nsp1 and
nsp1, PLP1 autocleaves between nsp1/and nsp2, and PLP2
cleaves between nsp2 and nsp3, which mediates the rapid release
of nsp1, nsp1, and nsp2 from the polyprotein (20). Recently,
two novel PRRSV proteins, nsp2TF and nsp2N, were identified
(21). nsp2TF and nsp2N are expressed by a novel 2/1 pro-
grammed ribosomal frameshifting (PRF) mechanism, which ac-
cesses the alternative ORF (TF) through a frameshifting site that
overlaps the nsp2-encoding region. Both nsp2TF andnsp2N share
the N-terminal two-thirds sequence of nsp2, which contains the
PLP2 domain.
Previous studies from our laboratory and others identified
PRRSV nsp1 to be a strong innate immune antagonist (22–24).
PRRSV nsp1 has strong inhibitory effects on type I interferon
(IFN) production and signaling pathways that lead to the expres-
sion of interferon-stimulated genes (ISGs). Interestingly, this pro-
tein was recently identified to also function as a transactivator for
the expression of the 2/1 PRF products nsp2TF and nsp2N
(25). Embedded in nsp1’s papain-like autoproteinase domain
(PLP1), a highly conserved GKYLQRRLQ motif was identified
to be critical for 2/1 PRF transactivation and the innate im-
mune suppression function of the virus (25, 26). Based on crystal
structure analysis, three basic residues (K124, R128, and R129) in
the GKYLQRRLQmotif are exposed on the surface of the protein
(25). In this study, we further investigated the function of the basic
residues K124, R128, andR129 involved in themodulation of host
immune responses. Recombinant viruses carrying mutations in
these basic residues were created and characterized in cell culture
systems as well as in a nursery piglet model.
MATERIALS AND METHODS
Cells and viruses. HEK-293T cells andMARC-145 cells were maintained
in minimum essential medium (MEM) (Gibco) supplemented with 10%
fetal bovine serum and antibiotic (streptomycin [100 g/ml]) at 37°C
with 5%CO2. BHK-21 cells were cultured inminimum essential medium
supplemented with 5% fetal bovine serum and antibiotic (streptomycin
[100 g/ml]). As described previously, porcine alveolar macrophages
(PAMs) were obtained from lung lavage samples of 6-week-old PRRSV-
naive piglets (27). The Sendai virus (SeV) Cantell strain, grown in embry-
onated chicken eggs, was used for stimulation of the type I IFN response in
the cell culture system. Type 2 PRRSV isolate SD95-21 (GenBank acces-
sion no. KC469618) and its nsp1 mutants were used for subsequent
experiments.
Antibodies.Todetect the expression of nsp1 and itsmutants,mono-
clonal antibody (MAb) 123-128 (25) or anti-FLAG M2 MAb (Sigma-
Aldrich, St. Louis, MO) was used. MAb 140-68 (25), which specifically
recognizes the common N-terminal PLP2 domain of nsp2, nsp2TF, and
nsp2N, was used to detect the expression of nsp2-related proteins. A rab-
bit polyclonal antibody against nsp2TF (PAb-TF) (25) was utilized to
immunoprecipitate and detect nsp2TF. In addition, an anti--tubulin
MAb (abm Inc., BC, Canada) was used to detect the expression of the
housekeeping gene -tubulin. An antibody mixture of MAb M2 against
FLAG and anti--tubulin was used for the simultaneous detection of the
expression of FLAG-tagged nsp1 and-tubulin inWestern blots (WBs),
while an antibody mixture of MAb 123-128 and anti--tubulin was used
for the simultaneous detection of the expression of nsp1 and -tubulin
in Western blots.
Plasmids. By using the nsp1-expressing plasmid (p3xFLAG-NA-
nsp1) that we generated previously (26), specific mutations, K124A,
R128A, R129A, or RR129AA (double mutation of R128A and R129A), in
the GKYLQRRLQ motif region (amino acids 123 to 131) of nsp1 were
introduced by site-directed mutagenesis using a QuikChange site-di-
rected mutagenesis kit (Agilent Technologies Inc., Santa Clara, CA) ac-
cording to the manufacturer’s instructions. A vaccinia virus-T7 polymer-
ase system (pL-NA-nsp1-2) expressing nsp1-nsp2 of SD95-21 virus
was described previously (26). Specific mutations (K124A, R128A,
R129A, or RR129AA) were introduced into the nsp1 region of pL-NA-
nsp1-2 by using a QuikChange site-directed mutagenesis kit. To gener-
ate full-length PRRSV cDNA clones containing these specific mutations
(R128A, R129A, or RR129AA), a shuttle plasmid carrying the region be-
tween two unique restriction sites (SphI and ScaI) of the full-length cDNA
clone of PRRSV (pCMV-SD95-21) was constructed by using a Zero Blunt
PCR cloning kit (Invitrogen, Carlsbad, CA). A QuikChange site-directed
mutagenesis kit (Agilent Technologies Inc., Santa Clara, CA) was em-
ployed to introduce the specific mutations into the shuttle plasmid. The
region between SphI and ScaI of pCMV-SD95-21 was replaced by the
corresponding regions of the shuttle plasmids containing the specificmu-
tations. The mutated full-length cDNA clones were designated pCMV-
SD95-21-R128A, pCMV-SD95-21-R129A, and pCMV-SD95-21-RR129AA.
DNA sequencing was further performed to verify the introduced muta-
tions. For in vitro luciferase reporter assays, two reporter plasmids, p125-
Luc and pISRE-Luc, were used as described previously (26).
Luciferase reporter assay. HEK-293T cells were seeded at 0.5  105
cells/ml into 24-well plates 1 day before transfection. DNA transfection
was conducted by using FuGENE HD transfection reagent (Promega,
Madison, WI). Briefly, cells were cotransfected with 0.5 g plasmid DNA
expressing wild-type (WT) nsp1 (or its mutants) and 0.5 g luciferase
reporter plasmid DNA of p125-Luc or pISRE-Luc. At 24 h posttransfec-
tion, cells were mock treated, stimulated with SeV inoculated at 100 hem-
agglutination (HA) units/ml/well for 16 h, or treated with IFN- at 2,000
IU/ml/well for 16 h. Cells were lysed and used for reporter gene assays
using the dual-luciferase reporter system (Promega, Madison, WI) ac-
cording to the manufacturer’s instructions. Firefly luciferase activities
were measured with FLUOstar Omega reader (BMG Labtech, Cary, NC).
Vaccinia virus-T7 polymerase expression system. nsp1-nsp2 and
its mutants were expressed by using a vaccinia virus-T7 polymerase sys-
tem (28) as described previously (26). Briefly, HEK-293T cells (1  106
cells/well) were seeded into 6-well plates 1 day before infection. Cells in
each well were infected with a vaccinia virus expressing T7 polymerase at
a multiplicity of infection (MOI) of 10. At 1 h postinfection (hpi), cells
were transfected with 2 g DNA of pL-NA-nsp1-2 or its mutants by
using FuGENEHD transfection reagent (Promega,Madison,WI). At 18 h
posttransfection, the cell lysate from each well of the 6-well plate was
harvested and subjected toWestern blot analysis using antibodies against
nsp1 (MAb 123-128) and nsp2 (MAb 140-68). In addition, the cell lysate
was used for immunoprecipitation (IP) assays to evaluate the expression
of the 2 PRF product with an antibody that specifically recognizes
nsp2TF (PAb-TF).
Western blot analysis. Western blot analysis was performed to eval-
uate protein expression according to methods described previously (20,
26). Briefly, cell lysates were prepared by harvesting virus-infected or plas-
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mid DNA-transfected cells with radioimmunoprecipitation assay (RIPA)
buffer. The cell lysate wasmixedwith an equal volume of Laemmli sample
buffer and heated at 95°C for 6 min. After being separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), proteins
were transferred onto a nitrocellulose membrane. The membrane was
blocked with 5% skim milk in PBST (phosphate-buffered saline [PBS]
with 0.05% Tween 20) at 4°C overnight and then incubated with primary
antibody at the appropriate dilution at room temperature for 1 h. After
washing three times with PBST, IRDye 800CW goat anti-mouse
IgG(HL) and/or IRDye 680RDgoat anti-rabbit IgG(HL) (Li-Cor Bio-
sciences, Lincoln, NE) secondary antibody was added, and themembrane
was incubated for an additional 1 h at room temperature. The target
proteins were visualized and quantified by using a digital image system
(Odyssey infrared imaging system; Li-Cor Biosciences, Lincoln, NE). For
quantification of the target proteins, the expression levels were normal-
ized to the expression level of -tubulin, which is a housekeeping gene
used as a loading control.
Recovery of recombinant viruses from infectious cDNA clones. The
procedure for generating recombinant viruses was described previously
(26). BHK-21 cells at 70 to 80% confluence were transfected with 2 g of
the type 2 PRRSV full-length cDNA clone of pCMV-SD95-21 or full-
length cDNA clones containing nsp1 mutations. Transfection was per-
formed by using FuGENE HD reagent (Promega, Madison, WI). At 48 h
posttransfection, the cell culture supernatant was harvested and passaged
on MARC-145 cells. After 48 to 60 h of incubation, indirect immunoflu-
orescence assays were performed to confirm the viability of recombinant
viruses by using MAb SDOW17 (PRRSV N protein-specific monoclonal
antibody) (29). The recombinant viruses were serially passaged on
MARC-145 cells, and passage 3 and 4 viruses were used for further anal-
ysis.
Sequencing of nsp1mutation regions. To determine the stability of
eachmutation, cell culture supernatants from recombinant virus-infected
cells or serum samples collected from experimentally infected animals (at
14, 21, and 35 days postinfection [dpi])were used for viral RNAextraction
using the QIAamp viral RNA kit (Qiagen). The nsp1 coding region con-
taining the corresponding mutations was amplified by reverse transcrip-
tion-PCR (RT-PCR), and PCR products were subjected to DNA sequenc-
ing at Genewiz Inc. (South Plainfield, NJ).
Virus growth kinetics and plaque assay. WT and mutant viruses at
passage 3 were used to characterize virus growth properties in vitro. Con-
fluent MARC-145 cells were inoculated with the WT virus or nsp1mu-
tants at an MOI of 0.01. The cell culture supernatant was harvested at 12,
24, 36, 48, 60, and 72 h postinfection. The virus titer was measured by a
microtitration assay using MARC-145 cells in 96-well plates and calcu-
lated as 50% tissue culture infective doses (TCID50) per milliliter accord-
ing to the method of Reed and Muench (30). To determine the plaque
morphology of the WT virus and nsp1 mutants, a plaque assay was
conducted by using MARC-145 cells as described previously (31).
Pig groups and sample collection and preparation. A total of 45 spe-
cific-pathogen-free (SPF) pigs were obtained from the swine farm of The
Ohio State University. Pigs were randomly divided into 5 groups (n	 9)
(Table 1). Pigs were mock infected (group 1) or infected with 4  106
TCID50 of WT PRRSV (group 2), the vR128A mutant (group 3), the
vR129Amutant (group 4), or the vRR129AAmutant (group 5). Pigs were
inoculated by both the intranasal (i.n.) and intramuscular (i.m.) routes
with 1ml (1 106 TCID50) of the virus injected into each nostril and into
each side of the neck. Pigs were observed daily, and blood samples were
collected at 0, 1, 2, 5, 7, 14, 21, 28, and 35 dpi. Three pigs from each group
were sequentially euthanized at 7, 21, and 35 dpi (Table 1). During nec-
ropsy, lungs were evaluated for gross lesions by using a method described
previously (32), and bronchoalveolar lavage fluid (BALF) and lung tissue
samples were collected as described previously (33). The pig experiment
was performed according to protocols approved by the Institutional An-
imal Care and Use Committee (IACUC) of The Ohio State University.
Real-time RT-PCR quantification of viral load in infected animals.
For the determination of viral RNA load, serum, BALF, and lung lysate
samples were examined by using real-time quantitative RT-PCR (qRT-
PCR). Briefly, viral genomic RNA was extracted by using a MagMAX-96
viral RNA isolation kit (Life Technologies) according to the manufactur-
er’s instructions. The viral RNA level was determined by quantitative RT-
PCRusing an iTaqUniversal SYBR green one-step kit (Bio-Rad,Hercules,
CA), and the RNA copy numbers were calculated based on an RNA stan-
dard curve. A pair of primers, PRRS-qF1 (CCATTTCCTTGACACAG
TCG) and PRRS21-qR2 (GACCGCGTAGATGCTACTTAGG), located at
the viral genomic region (nucleotides [nt] 14043 to 14130), was designed
for real-time RT-PCR. The RNA standard was prepared by in vitro tran-
scription. Briefly, the viral genomic region (nt 13918 to 14246) was am-
plified by RT-PCR using primers T7-GP5F (TCTAGATAATACGACTC
ACTATAGGGAACTTGACGCTATGTGAGCTG [underlining indicates
the T7 promoter]) and GP5R (TAGAGTCTGCCCTTAGTGTCCA). The
PCR product was purified and subjected to in vitro transcription by using
a MEGAscript T7 transcription kit (Invitrogen, Carlsbad, CA). The puri-
fied RNA product was used as the quantification standard.
Quantitative analysis of mRNA. Porcine alveolar macrophages were
infected with the WT virus or nsp1 mutants at an MOI of 1. At 12 h
postinfection, PAMswere harvestedwithTRIzol LS (Ambion, FosterCity,
TABLE 1 Experimental design for testing of nsp1mutants in nursery pigs
Procedure dpi
Pigs in treatment group
Negative control
(group 1) WTe (group 2) R128A (group 3) R129A (group 4) RR129AA (group 5)
Blood collectiona 0 1–9c 10–18 19–27 28–36 37–45
1 1–9 10–18 19–27 28–36 37–45
2 1–9 10–18 19–27 28–36 37–45
5 1–9 10–18 19–27 28–36 37–45
14 4–9 14–18 22–27 31–36 40–45
28 7–9 17, 18 25–27 34–36 43–45
Animal terminationb 7 1–3d 10, 11, 13 19–21 28–30 37–39
21 4–6 14–16 22–24 31–33 40–42
35 7–9 17, 18 25–27 34–36 43–45
a At 0, 1, 2, 5, 14, and 28 dpi, plasma and PBMCs were collected.
b At 7, 21, and 35 dpi, 3 pigs from each group were terminated, and their plasma, PBMCs, bronchoalveolar lavage fluid, and lung tissue samples were collected.
c Pigs for blood collection at the indicated time point.
d Pigs terminated at the indicated time point.
e Pig 12 died before 7 dpi.
Li et al.
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CA) and subjected to total RNA extraction according to the manufactur-
er’s instructions. After removal of contaminating genomic DNA with a
Turbo DNA-free kit (Invitrogen, Carlsbad, CA), 1g total RNAwas used
to synthesize first-strand cDNA by using a SuperScript Vilo cDNA syn-
thesis kit (Invitrogen, Carlsbad, CA). Subsequently, real-time PCR was
performed to quantify the expression ofmRNAs of ISG15, IFIT1, IFITM1,
and -tubulin by using predesigned primer/probe sets (Applied Biosys-
tems, Foster City, CA) according to the manufacturer’s instructions. The
amounts of ISG15, IFIT1, and IFITM1 mRNAs were normalized to the
amount of endogenous -tubulin mRNA.
Analysis of the swine cytokine response. Porcine alveolar macro-
phages were infected with theWT virus or nsp1mutants at anMOI of 1.
At 12 h postinfection, the cell culture supernatant was harvested for anal-
ysis of IFN- expression using a ProcartaPlex Porcine IFN alpha Simplex
kit (eBioscience, San Diego, CA). In addition, Serum, BALF, and lung
lysate samples were used formeasuring the levels of the secreted cytokines
IFN-, IFN-
, interleukin-6 (IL-6), and IL-10 by an enzyme-linked im-
munosorbent assay (ELISA), as described previously (34).
Pig NK cell cytotoxic assay. To determine pig natural killer (NK)
cell-mediated cytotoxicity, an immunofluorescence-based assay was per-
formed by using a modified method described previously (34–36). The
assay was conducted by using a 7-aminoactinomycin D (7-AAD)/car-
boxyfluorescein succinimidyl ester (CFSE) cell-mediated cytotoxicity as-
say kit (Cayman Chemical, Ann Arbor, MI). Briefly, peripheral blood
mononuclear cells (PBMCs) isolated from pigs were used as the source of
NK cells (effectors) against K562 (human myeloblastoid cell line) target
cells. The target cells were labeled with CFSE according to the manufac-
turer’s recommendations. Effector and target cells were incubated at dif-
ferent effector-to-target cell (E:T) ratios at 37°C overnight. The frequency
of CFSE-labeled apoptotic K562 cells was measured by staining the cocul-
tured target cells with 7-AAD nuclear dye. Specific NK cell cytotoxicity
wasmeasured by flow cytometry by acquiring 10,000 CFSE-labeled events
and further gated for the frequency of CFSE and 7-AAD (green and red)
double-stained cells, which indicates the frequency of lysed target cells.
Appropriate controls included K562 cells labeled or unlabeled with CFSE
and apoptosis-induced K562 cells (treated with UV at 254 nm for 30 min
and then incubated for 6 to 8 h at 37°C). The percentage of NK cell-
specific lysis was calculated by using the following formula: number of
double-positive K562 cells/number of CFSE-positive K562 cells multi-
plied by 100.
Flow cytometry analysis. Immunophenotyping of PBMCs was per-
formed as previously described (33, 37). Briefly, PBMCs were first surface
labeled with pig lymphocyte-specific fluorochrome-conjugated MAbs
(CD3ε-peridinin chlorophyll protein [PerCP], CD4-allophycocyanin
[APC], and CD8-fluorescein isothiocyanate [FITC]). For intracellular
IFN-
 staining, GolgiPlug (BD Biosciences, San Jose, CA, USA) and
brefeldin A (catalog number B7651; Sigma-Aldrich, St. Louis, MO) were
added during the last 12 h of incubation of PBMCs treatedwith orwithout
the respective virus as a stimulant at an MOI of 1. The surface-immuno-
stained cells were fixed with 1% paraformaldehyde and permeabilized
with a cell permeabilization buffer (85.9% deionized water, 11% PBS
without Ca2 or Mg2, 3% formaldehyde solution, and 0.1% saponin)
overnight at 4°C. Cells were washed and stained with fluorochrome-con-
jugated anti-pig IFN-
 or the isotype control MAb (BD Biosciences, East
Rutherford, NJ) in 0.1% saponin-containing fluorescence-activated cell
sorter (FACS) buffer. Finally, 25,000 immunostained cells were acquired
using a FACSAria II flow cytometer (BDBiosciences, East Rutherford,NJ)
and the data were analyzed using FlowJo software (Tree Star, Ashland,
OR, USA). All cell population frequencies are presented as percentages of
specific lymphocytes in PBMCs.
Statistical analysis. All the data were expressed as themeans of results
from 3 to 9 pigs standard errors of themeans (SEM). Statistical analyses
were performedbyusing one-way analysis of variance (ANOVA) followed
by Tukey’s post hoc test using GraphPad InStat Prism software (version
5.0) to establish variations between the indicated pig groups. Statistical
significance was assessed at P values of0.05,0.01, and0.001.
RESULTS
Identification of critical residues in the GKYLQRRLQ motif for
PRRSV nsp1 function. In our previous study (26), we identified
a highly conserved GKYLQRRLQ motif in PRRSV nsp1 that is
critical for the innate immune suppression function of this pro-
tein. Protein structural analysis showed that three basic residues
(K124, R128, andR129) in theGKYLQRRLQmotif (boldface type
indicates the positions of the three basic residues) are exposed on
the surface of nsp1 (25). In this study, we further investigated the
function of these three basic residues. A panel of nsp1 mutants
was generated. Each of the nsp1 genes carries a single alanine
substitution at amino acid K124 (K124A), R128 (R128A), and
R129 (R129A) or a double alanine substitution at R128/R129
(RR129AA). A previously created mutant, nsp1KO (1KO)
(R124/R128-to-A124/A128 double substitution) (26), was also in-
cluded in the analysis. These nsp1mutants were cloned into the
plasmid vector p3xFLAG-Myc-CMV-23, in which gene expres-
sion is under the control of a cytomegalovirus (CMV) promoter,
and expressed as a 3xFLAG-tagged protein. Initially, this panel of
nsp1mutants was analyzed by an IFN- promoter-driven lucif-
erase reporter assay. HEK-293T cells were cotransfected with a
plasmid expressing wild-type (WT) or mutated nsp1 and a re-
porter plasmid (p125-Luc) that expresses the firefly luciferase re-
porter gene under the control of the IFN- promoter. The empty
vector p3xFLAG-Myc-CMV-23 was included in the analysis as a
control. At 24 h posttransfection, cells were mock infected or in-
fected with Sendai virus (SeV). Cells were harvested to test the
luciferase activities at 16 h postinfection (hpi). As shown in Fig.
1A, SeV infection induced a high level of luciferase reporter ex-
pression in cells transfected with the empty vector, but the lucif-
erase expression level was46- to 16-fold lower in cells expressing
WT nsp1 and the K124A mutant. In contrast, 33-fold-, 19-
fold-, 24-fold-, and 26-fold-higher levels of reporter expression
were detected in cells expressing the R128A, R129A, RR129AA,
and 1KO mutants, respectively, than in cells expressing WT
nsp1. We further determined whether these mutations had an
effect on the ability of nsp1 to suppress the IFN-dependent sig-
naling pathway for interferon-stimulated gene (ISG) expression.
The panel of nsp1mutants was analyzed by using an interferon-
stimulated response element (ISRE) promoter-driven luciferase
reporter assay. Results similar to those shown in Fig. 1A were
generated. In comparison to those cells expressing WT nsp1,
there were about 38-fold-, 46-fold-, 75-fold-, and 71-fold-higher
levels of reporter expression detected in cells expressing the
R128A, R129A, RR129AA, and 1KO mutants, respectively (Fig.
1B). These results suggest that R128 and R129 are critical to the
IFN antagonist function of nsp1. In contrast, K124 appeared not
to significantly affect the IFN antagonist function of nsp1.
The expression level of nsp1 was evaluated by Western blot
analysis using MAb M2 against the FLAG tag. The results con-
firmed the expression of nsp1 in WT- and mutant-transfected
cells used in luciferase assays (Fig. 1C). In our previous study, we
showed that a double mutation of K124/R128 to A124/A128
caused increased levels of nsp1 expression in comparison to
those of WT nsp1 and other mutants, which suggested that
nsp1may suppress its “self-expression” (26). In this study, indi-
vidual substitutions introduced at K124, R128, and R129 showed
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that only the R128A substitution affects the ability of nsp1 to
suppress self-expression in vitro. The detailed mechanism for the
ability of nsp1 to suppress self-expression and whether such a
property relates to the innate immune suppression function of the
virus need to be further studied (see Discussion, below).
We further determinedwhethermutations introduced into the
GKYLQRRLQ motif also affect the transactivator function of
nsp1. A vaccinia virus-T7 polymerase system expressing the
nsp1-nsp2 (nsp1-2) region was used to analyze the expression
of nsp2 and PRF products. The expression of the2 PRF product
(nsp2TF) was determined by immunoprecipitation (IP) and
Western blot (WB) assays. Equal amounts of lysates of transfected
cells expressing WT nsp1-2 or its mutants (K124A, R128A,
R129A, 1KO, and RR129AA)were subjected to immunoprecipi-
tation using a polyclonal antibody (PAb-TF) that specifically rec-
ognizes the C-terminal peptide of nsp2TF. Subsequently,Western
blot analysis was performed by using PAb-TF and MAb 140-68,
which recognizes the N-terminal PLP2 domain of the protein. As
shown in Fig. 2A, the nsp2TF product was detected only in cells
expressing WT nsp1-2 or the K124A mutant but not in cells
expressing the R128A, R129A, RR129AA, and 1KO mutants. In
contrast, the expression of full-length nsp2 and nsp1 was de-
tected in the WT and all nsp1-2 mutants (Fig. 2B). The results
indicate that residues R128 and R129 are critical for the transacti-
vator function of nsp1 in activating the2 PRF signal. K124 did
not show a significant effect on the nsp1 function in PRF trans-
activation.
In vitro characterization of recombinant viruses containing
mutations in the GKYLQRRLQ motif. To further investigate
whether the specific substitutions introduced into the nsp1 GK
YLQRRLQ motif of the virus could improve innate immune re-
sponses in PRRSV-infected cells, we created a panel of recombi-
nant viruses using a reverse-genetics approach. Three viable
recombinant viruses were generated, vSD95-21-R128A
(vR128A), vSD95-21-R129A (vR129A), and vSD95-21-R128A/
R129A (vRR129AA), carrying single or double mutations at res-
idues R128 andR129 of theGKYLQRRLQmotif. For comparison,
recombinant viruses with a mutation at K124 (vSD95-21-K124A
[vK124A]) and a double mutation at K124/R128 (vSD95-21-
K124A/R128A [v1KO]) and the WT virus vSD95-21 were also
recovered by the reverse-genetics approach. The stability of these
mutations introduced into the virus was determined by serially
passaging each virus 5 times in MARC-145 cells, and sequence
analysis of passage 3 and passage 5 viruses showed that all of the
introduced mutations were stably maintained in the mutant vi-
ruses. The growth properties of these mutants (passage 3) were
compared with those of the WT parental virus. In comparison to
the WT virus (peak virus titer of 107.33 TCID50/ml), vK124A
showed a similar growth ability, while vR128A and vR129A
showed certain levels of reduced growth ability (peak virus titers
FIG 1 Mutations in the GKYLQRRLQ motif impair nsp1’s inhibitory effect on type I interferon production and signaling. (A and B) HEK-293T cells in a
24-well plate were cotransfected with a plasmid expressingWTnsp1 or the nsp1mutant, the p125-Luc reporter plasmid expressing firefly luciferase under the
control of the IFN- promoter (A) or pISRE-Luc expressing firefly luciferase derived from the interferon-stimulated response element (ISRE) (B). An empty
vector (EV) was used as a control. At 24 h posttransfection, cells were stimulated with SeV at 100 HA units/ml or stimulated with IFN- at 2,000 IU/ml for 16 h.
Cell lysates were harvested for measurement of luciferase activity. (C) The expression level of nsp1was evaluated byWestern blot analysis using nsp1-specific
MAb 123-128. -Tubulin was detected as a loading control. The membrane was incubated with a mixture of primary anti-FLAGM2 MAb (Sigma-Aldrich, St.
Louis, MO) and MAb against -tubulin. The secondary antibody IRDye 800CW goat anti-mouse IgG(HL) (Li-Cor Biosciences, Lincoln, NE) was used for
visualizing the target proteins with a digital image system (Odyssey infrared imaging system; Li-Cor Biosciences, Lincoln, NE). The expression of nsp1 was
quantified and normalized to the expression level of -tubulin, and the relative expression levels are shown under each band. Statistical significance between the
wild-type virus-infected group and themutant virus-infected group was determined by one-way ANOVA and Tukey’s test and is indicated with asterisks (*, P
0.05; **, P 0.01; ***, P 0.001).
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of 107.0 TCID50/ml and 10
6.58 TCID50/ml, respectively). In con-
trast, the vRR129AA and v1KO mutants had significantly re-
duced growth abilities, with1- to 1.5-log decreases in virus titers
throughout the time course of the study (Fig. 3A). Plaque assay
results consistently showed that v1KO and vRR129AA devel-
oped smaller plaques than did the WT virus (Fig. 3B).
Expression of innate immune genes in nsp1mutant virus-
infected cells. As we determined that the R128A and/or R129A
mutation introduced into the GKYLQRRLQ motif reduced the
ability of nsp1 to suppress the innate immune response (Fig. 1),
we further analyzed whether these mutations could alter the in-
hibitory effect of PRRSV on type I IFN production and signaling.
Since K124A did not show much of an effect on the function of
nsp1 in PRF transactivation and innate immune suppression,
recombinant viruses containing the K124A substitution (vK124A
and v1KO) were not further analyzed in the following experi-
ments (for more about the characteristics of v1KO, see Discus-
sion, below). Initially, IFN- expression was evaluated in nsp1
mutants or WT virus-infected porcine alveolar macrophages
(PAMs) by using a ProcartaPlex Porcine IFN alpha Simplex kit
(eBioscience, San Diego, CA). PAMs were initially infected with
equal amounts (MOI	 1) of theWT or an nsp1mutant. At 12 h
postinfection, the IFN- concentration in the cell culture super-
natant of virus-infected PAMs was evaluated. All of the nsp1
mutants showed an improved ability to induce the production of
IFN-, which is indicated by the 3.3-fold-higher (vR128A), 6.1-
fold-higher (vR129A), and 50-fold-higher (vRR129AA) concen-
trations of IFN- in the supernatants of cells infected withmutant
viruses than in the supernatant of WT virus-infected cells (Fig.
4A). Of note, vRR129AA showed the strongest stimulation of
IFN- production. In addition, the expression of nsp1 was de-
tected by Western blotting, indicating successful viral replication
ofWT virus and nsp1mutants in PAMs (Fig. 4E). Subsequently,
we analyzed whether these mutations could alter the inhibitory
effect of PRRSV on the production of ISGs. At 12 h postinfection,
the mRNA expression levels of three selected ISGs, ISG15, IFIT1,
and IFITM1, were assessed by quantitative real-time RT-PCR
(qRT-PCR)using predesigned primer/probe sets (AppliedBiosys-
tems, Foster City, CA). Consistent with their improved ability for
IFN- induction, all of the nsp1 mutants stimulated higher
mRNA expression levels of ISGs. As indicated in Fig. 4B, 4.1-
fold-higher (vR128A), 7.8-fold-higher (vR129A), and 20-fold-
higher (vRR129AA) mRNA expression levels of ISG15 were de-
tected in mutant virus-infected cells than that in WT virus-
infected cells, although the increases in vR128A- and vR129A-
infected cells are not statistically significant. Similarly, the mRNA
expression levels of IFIT1 and IFITM1 were increased in mutant
virus-infected cells in comparison to those in WT virus-infected
cells (Fig. 4C and D).
In vivo characterization of nsp1mutants. Subsequently, we
obtained five groups of 4-week-old pigs to determine whether the
R128- and R129-related mutants could improve specific immune
FIG 2 Mutations at R128 andR129 in theGKYLQRRLQmotif impair the expression of nsp2TF in the vaccinia virus-T7 expression system.HEK-293T cells were
infected with vaccinia virus expressing T7 polymerase at anMOI of 10 and then transfected with pLnsp1-2 constructs at 1 h postinfection. The cell lysates were
harvested at 18 h posttransfection. (A) nsp2TF was immunoprecipitated by a polyclonal antibody (PAb-TF) that specifically recognizes the C-terminal region of
nsp2TFusing equal amounts of the cell lysate. Immunoprecipitated proteinswere detected byWBusing PAb-TF (top) andMAb140-68 recognizing the common
N-terminal region of nsp2-related proteins (bottom). (B) Western blot detection of the expression of nsp2 (top) and nsp1 (bottom) using specific MAbs.
FIG 3 In vitro characterization of recombinant viruses containing nsp1mu-
tations. (A) Multiple-step virus growth curve. Each data point shown repre-
sents the mean value from duplicates, and error bars show SEM. (B) Plaque
morphology of WT and recombinant viruses containing mutations in the
GKYLQRRLQ motif of nsp1.
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responses in PRRSV-infected pigs. As shown in Table 1, each
group of pigs (n	 9) was infected with theWT virus or an nsp1
mutant or mock infected with cell culture medium as a negative
control. Serum, BALF, and lung lysate samples were collected and
stored at80°C for further analysis. We did not observe any no-
ticeable clinical PRRS symptoms and fever in any of theWT virus-
or nsp1mutant-infected pigs.
Viral load in serum and tissue samples. Initially, wemeasured
viral RNA loads in serum samples using real-time qRT-PCR. In
comparison with the group of pigs infected with the WT virus,
pigs infected with the vR128A and vRR129AA mutants showed
consistently lower viral RNA loads throughout the entire time
course of the experiment, while pigs infected with the vR129A
mutant exhibited lower viral RNA loads from 1 dpi to14 dpi (Fig.
5A). Statistically significantly lower levels of viral RNA were ob-
tained at 1, 2, 5, and 14 dpi in pigs infected with the vR128A
FIG 4 Mutations in the GKYLQRRLQmotif attenuate the ability of PRRSV to suppress the expression of IFN- and ISGs. Porcine alveolar macrophages seeded
into a 24-well plate were infected with the WT virus or nsp1mutants at an MOI of 1.0, and cell culture supernatants were harvested at 12 h postinfection. (A)
IFN- production was quantified by using a ProcartaPlex Porcine IFN alpha Simplex kit (eBioscience, San Diego, CA). Each data point shown represents the
mean value from three independent experiments with duplicates, and error bars show SEM. (B) The mRNA expression level of ISG15 was evaluated by
quantitative real-time RT-PCR and normalized to the level of endogenous -tubulin mRNA. (C) The mRNA expression level of IFIT1 was evaluated by quan-
titative real-timeRT-PCR and normalized to the level of endogenous-tubulinmRNA. (D) ThemRNA expression level of IFITM1was evaluated by quantitative
real-time RT-PCR and normalized to the level of endogenous -tubulin mRNA. Values in panels B to D are expressed as means SEM from three independent
experiments. (E) The expression level of nsp1 at 12 h postinfection was determined byWestern blot analysis with nsp1-specificMAb 123-128. -Tubulin was
detected as a loading control. Themembranewas incubatedwith amixture of primaryMAb 123-128 andMAb against-tubulin. The secondary antibody IRDye
800CW goat anti-mouse IgG(HL) (Li-Cor Biosciences, Lincoln, NE) was used to visualize the target proteins with a digital image system (Odyssey infrared
imaging system; Li-Cor Biosciences, Lincoln, NE). Statistical significance between the wild-type virus-infected group and mutant virus-infected groups was
determined by one-way ANOVA and Tukey’s test and is indicated with asterisks (*, P 0.05; **, P 0.01; ***, P 0.001).
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mutant than in pigs infected with theWT virus (Fig. 5A). At most
of the time points during the later stage of infection (14 to 35 dpi),
the mean viral RNA load in pigs infected with the vRR129AA
mutant was the lowest among all the infected pigs (Fig. 5A). Sur-
prisingly, vR129A mutant-infected pigs showed mean viral RNA
loads that were similar to those of the group of pigs infected with
the WT virus at 21 dpi and exhibited higher (but not statistically
significant) viral RNA loads than those of pigs infected with the
WT virus at 28 dpi and 35 dpi.
Since qRT-PCR does not distinguish between viable and non-
viable forms of the virus, we further quantified infectious virus
particles in serum samples. The infectious virus titer was mea-
sured by amicrotitration assay usingMARC-145 cells. At 1, 2, and
5 dpi, infectious virus titers in groups of pigs infected with nsp1
mutants were1 to 3 logs lower (statistically significant) than the
virus titers in pigs infected with the WT virus (Fig. 5B), which is
consistent with viral loads quantified by qRT-PCR (Fig. 5A). The
infectious virus titer in many pigs infected with nsp1 mutants
was lower than the detection limit (101.67 TCID50/ml) of the mi-
crotitration assay throughout the time course of infection. A re-
bounded virus titer was observed for vR129A mutant-infected
pigs at 21, 28, and 35 dpi, which is consistent with the viral RNA
load result generated by qRT-PCR. These results indicate that the
growth abilities of vR128A and vRR129AAwere attenuated in vivo
and that the growth ability of vR129A was attenuated at an early
stage of infection but reverted to the WT phenotype at a certain
level during the later stage of infection (Table 2).
Since PAMs serve as the primary target cells for PRRSV, we
further evaluated the viral load in lung lysates and BALF collected
at 7, 21, and 35 dpi. The viral RNA load was quantified by qRT-
PCR, and the infectious virus titer was determined by a microti-
tration assay. Results from both qRT-PCR and microtitration as-
says showed that the viral loads in lung lysates and BALF from all
groups of pigs infected with nsp1 mutants were consistently
lower than those in pigs infected with theWT virus at 7 and 21 dpi
(Fig. 6), although some of the differences were not statistically
significant. At 35 dpi, lower mean viral loads and infectious virus
titers were detected in lung samples from pigs infected with the
vR128A and vRR129AA mutants than in pigs infected with the
WT virus (Fig. 6). Themean viral loads in lung samples and BALF
from vR129A mutant-infected pigs were similar to those in WT
virus-infected pigs at 35 dpi. These results suggest that nsp1mu-
tants have an attenuated replication ability in the lungs of infected
pigs, but vR129A showed a reversion to the WT phenotype at
certain levels during the later stage of infection.
Genetic stability of nsp1mutants in pigs.Genetic stability is
one of the important criteria for selecting vaccine candidates. Ini-
tially, serum samples from 3 pigs per group terminated at 21 dpi
were used to determine the stability of the introduced mutations.
The nsp1 coding region was amplified by RT-PCR, and the PCR
product was subjected to DNA sequencing analysis. As shown in
Table 2, no second-site mutation and also no reversion were
found in the nsp1 coding region of the virus isolated from serum
samples of pigs infected by the vRR129AA mutant virus. In the
group of pigs infected with the vR128Amutant, the designedmu-
tation was maintained in the viruses recovered from all three
tested pigs, but several second-site mutations were observed, in-
cluding the replacement of Asp9 by Gly and the replacement of
Ser122 by Pro in all three pigs and the replacement of His109 and
Leu141 byArg andPro, respectively, in one pig. In the group of pigs
infectedwith the vR129Amutant, the designedmutation in one of
the three tested pigs reversed from Ala back to Arg (in the WT
virus), and the R129A mutation was maintained in the other two
pigs. Similar to the vR128A group, the second-site mutation of
Ser122 to Pro was detected in the two pigs that maintained the
designed mutation; an additional mutation of Ser169 to Pro oc-
curred in one of the two pigs, and the replacement of Asp9 by Gly
was observed in all three pigs. Since a reversion occurred in one of
the vR129A mutant-infected pigs at 21 dpi, we further analyzed
serum samples from all 6 pigs infected with vR129A at 14 dpi.
Remarkably, the pig with an Ala129-to-Arg reversion at 21 dpi had
already obtained the reversion at 14 dpi. However, the designed
R129Amutation was maintained in the other five pigs. It is worth
noting that the second-site mutation of Ser122 to Pro occurred in
all of the pigs thatmaintained the designedmutations (R128A and
R129A) at 14, 21, and 35 dpi, suggesting that this substitutionmay
compromise the effect of the designed mutations on virus growth
ability in vivo. Interestingly, the mutation of Asp9 to Gly was de-
tected not only in pigs infected with all mutants but also in pigs
infectedwith theWTvirus. Thismutationmay relate to the in vivo
fitness of PRRSV, which was most likely not caused by our de-
signed mutations. In addition, using serum samples at 35 dpi that
were determined to be PRRSV RNA positive by real-time RT-
PCR, no reversion was observed by sequencing analysis. We
searched PRRSV full-length genome sequences available in
GenBank (as of 27 July 2015), and all of the second-site substitu-
tions that were observed here can be found in field strains; for
example, the PRRSV P129 strain contains Pro122. Taken together,
among the three nsp1mutants, vRR129AA maintained the best
FIG 5 Comparison of viral loads in serum samples from pigs inoculated with
the WT virus and nsp1 mutants. Pigs were uninfected (mock) or infected
with WT PRRSV (WT) or the three indicated mutants (vR128A, vR129A,
vRR129AA). Serum samples were collected on the indicated days postinfec-
tion. (A) Viral loads in serum samples quantified by quantitative RT-PCR and
calculated as viral RNA copies per milliliter. (B) Infectious virus titer in serum
samples determined by amicrotitration assay and calculated as log TCID50 per
milliliter. Statistical significance between the wild-type virus-infected group
and mutant virus-infected groups was determined by one-way ANOVA and
Tukey’s test and are indicated with asterisks (*, P 0.05; **, P 0.01; ***, P
0.001).
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genetic stability in vivo, with no reversion and fewer second-site
mutations being detected in the nsp1 coding region.
Innate immune response in PRRSV nsp1 mutant-infected
pigs. To determine whether the mutations introduced into the
nsp1 region could improve the innate immune response, we
initially measured IFN- expression in infected and control pigs
during the early stage of infection. Compared to WT virus-in-
fected pigs, 1.5-fold-higher (but not significant) levels of IFN-
were observed in serum samples of vRR129AA-infected pigs at 1
dpi (data not shown). Since the virus replicates primarily in alve-
olar macrophages, we also inoculated the pigs by the intranasal
(i.n.) route, and as the immune response in the lung is important,
we measured IFN- levels in both BALF (representing airways)
and lung lysates (representing the lung parenchyma, a local site of
PRRSV infection). The IFN- levels in BALF at 7 dpi were com-
parable among all pig groups, while in pigs inoculated with the
TABLE 2 Sequence analysis of the nsp1 coding region in viruses recovered from infected pigs
Group Pig Designed mutation
Position of 2nd-site mutation, nucleotide substitution,
amino acid substitutiona
14 dpi
vR129A 31 Reversion (GCG to AGG)
32 Stable 122, UCU to CCU, Ser to Pro
33 Stable 122, UCU to CCU, Ser to Pro
34 Stable 122, UCU to CCU, Ser to Pro
35 Stable 122, UCU to CCU, Ser to Pro
36 Stable 122, UCU to CCU, Ser to Pro
21 dpi
WT 14 9, GAC to GGC, Asp to Gly
15 9, GAC to GGC, Asp to Gly
16 9, GAC to GGC, Asp to Gly
vR128A 22 Stable 9, GAC to GGC, Asp to Gly
122, UCU to CCU, Ser to Pro
23 Stable 9, GAC to GGC, Asp to Gly
122, UCU to CCU, Ser to Pro
24 Stable 9, GAC to GGC, Asp to Gly
109, CAU to C(A/G)U, His to His/Arg
122, UCU to CCU, Ser to Pro
141, CUA to C(U/C)A, Leu to Leu/Pro
vR129A 31 Reversion (GCG to AGG) 9, GAC to GGC, Asp to Gly
32 Stable 9, GAC to GGC, Asp to Gly
87, GAA to GA(A/G)
122, UCU to CCU, Ser to Pro
33 Stable 9, GAC to GGC, Asp to Gly
122, UCU to CCU, Ser to Pro





WT 17 9, GAC to GGC, Asp to Gly
126, CUA to CU(A/G)
18 9, GAC to GGC, Asp to Gly
vR128A 27 Stable 9, GAC to GGC, Asp to Gly
109, CAU to CGU, His to Arg
122, UCU to CCU, Ser to Pro
vR129A 34 Stable 9, GAC to GGC, Asp to Gly
122, UCU to CCU, Ser to Pro
132, UUU to (G/U)UU, Phe to Val
34 141, CUA to CU(A/G)
169, UCU to (C/U)CU, Ser to Ser/Pro
35 Stable 9, GAC to GGC, Asp to Gly
122, UCU to CCU, Ser to Pro
36 Stable 9, GAC to GGC, Asp to Gly
122, UCU to CCU, Ser to Pro
169, UCU to CCU, Ser to Pro
vRR129AA 44 Stable 9, GAC to GGC, Asp to Gly
45 Stable 9, GAC to GGC, Asp to Gly
a Numbers refer to codon positions in the nsp1 coding region.
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vRR129AA and vR129Amutants, therewas an increased level (but
not statistically significant) of IFN-production compared to that
in WT virus-infected pigs at 21 and 35 dpi (data not shown). At 7
dpi, higher levels of IFN-were observed in the lung lysates of pigs
inoculated with nsp1mutant viruses than in those of WT virus-
infected pigs (Fig. 7A).
IFN- is critical for natural killer (NK) cell-mediated cytotoxic
function. To determine whether the nsp1 mutations impaired
the IFN- antagonist function of the virus, PBMCs from mutant
and WT virus-infected pigs were used as a source of NK cells to
evaluate NK cell function in an NK cell cytotoxicity assay. At both
E:T ratios used (100:1 and 50:1), the vRR129AA mutant-infected
pigs had increased NK cell cytotoxic function at 7 dpi (Fig. 7B and
C). This result is consistent with the increased level of IFN- pro-
duction in the serum and lung lysates of vRR129AA-infected pigs.
Adaptive immune response in PRRSV nsp1 mutant-in-
fected pigs. A strong innate immune response following virus
infection augments cell-mediated adaptive immunity. Therefore,
we analyzed the production of an important Th1 cytokine, IFN-
,
in WT virus- and nsp1mutant-infected pigs. The production of
IFN-
 in the serum of WT virus-infected pigs was undetectable
throughout the time course of the study (0 to 35 dpi), while in the
serum of nsp1 mutant-infected pigs, spurts of IFN-
 secretion
(100 to 150 pg/ml) were detected on multiple days postinfection,
with IFN-
 being detected in vR129Amutant-infected pigs at 7 to
21 dpi and in vRR129AA mutant-infected pigs at 14 and 28 dpi
(Fig. 8A). In vR128Amutant-infected pigs, increased IFN-
 levels
were detected in serum at 5 and 14 dpi (Fig. 8A). Such an early
response of IFN-
 in nsp1mutant-infected pigs might be due to
the rescue of adaptive immunity mediated by the induction of
IFN- secretion and NK cell function by these mutants. A similar
increase in IFN-
 secretion (but not statistically significant) was
FIG 6 Comparison of viral loads in BALF and lung samples frompigs inoculated with theWT virus and nsp1mutants. Pigs were uninfected (mock) or infected
withWT PRRSV (WT) or the three indicatedmutants (vR128A, vR129A, and vRR129AA). Lungs harvested on the day of necropsy (7, 21, and 35 dpi) were used
for collecting BALF and lung lysates. (A andB)Viral loads in BALF (A) and lung lysate (B) sampleswere quantified by quantitative RT-PCR and calculated as viral
RNAcopies permilliliter of BALFor viral RNAcopies per gramof lung. (C andD) Infectious virus titers inBALF (C) and lung lysate (D) sampleswere determined
by a microtitration assay and calculated as log TCID50 per milliliter or log TCID50 per gram. A key explaining the treatment groups in panels B to D is given in
panel A. Statistical significance between the wild-type virus-infected group andmutant virus-infected groups was determined by one-way ANOVA and Tukey’s
test and is indicated with asterisks (**, P 0.01).
FIG 7 Comparison of IFN- production levels and NK cell cytotoxicity in
pigs inoculated with the WT virus and nsp1 mutants. Pigs were uninfected
(mock) or infected with WT PRRSV (WT) or the three indicated mutants
(vR128A, vR129A, and vRR129AA). (A) Lung samples collected at 7 dpi were
used to prepare lung lysates, and IFN- levels were analyzed by an ELISA. (B
and C) PBMCs (NK effectors) were harvested on the day of necropsy (7 dpi),
and cells were coculturedwith target cells (K562) at an E:T ratio of 100:1 (B) or
50:1 (C). After overnight incubation, theNK cell-specific cytotoxic activitywas
determined by flow cytometry. Each data point represents the mean value 
SEM of data from 3 pigs. Statistical significance between the wild-type virus-
infected group and mutant virus-infected groups was determined by one-way
ANOVA and Tukey’s test.
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detected in the BALF of vR128A-, vR129A-, and vRR129AA-in-
fected pigs, observed only at 7 dpi (data not shown). However, the
increased levels of IFN-
 production in the lung lysates of
vR129A- and vRR129AA-infected pigs at 7 dpi were significantly
higher than those in WT virus-infected pigs (Fig. 8B).
Production of the proinflammatory cytokine IL-6 suggests an
inflammatory reaction in the lungs of pigs (34). The levels of IL-6
were higher (but not significant) at 21 dpi in the BALF of vR129A-
and vRR129AA-infected pigs than in the BALF of WT virus-in-
fected pigs (Fig. 8C). At 21 dpi, significantly higher levels of IL-6
production were detected in the lung lysates of vRR129AA-in-
fected pigs than in WT virus-infected pigs (Fig. 8D). These data
suggest that the induction of IL-6 production by the vRR129AA
mutant in pigs appears to be responsible for augmenting IFN-

production, an indicator of adaptive immunity.
We further evaluated the frequencies of different T cell sub-
populations in PBMCs, expressed as the percentage of CD3 or
CD3 cells. Pig T cells expressing the CD3 CD4 CD8 com-
bination of phenotypicmarkers are either cytotoxic T cells (CTLs)
or 
T cells, andCD3CD4CD8 cells are exclusively CTLs
(38, 39). The porcine immune system has a unique frequency of
CD3 CD4 CD8 T cells, which have memory, cytotoxic, and
Thelper cell properties (40, 41). To determine the antigen-specific
activation of the T cell response, IFN-
-secreting lymphocyte sub-
sets were elucidated by restimulating PBMCs with the same virus
in vitro. For each experimentwith phenotypicmarker staining, the
respective isotype controls were included to eliminate the back-
ground. The specific population of cells was identified based on a
combination of phenotypic cell surface markers, which include
CD3 CD4 CD8 (CTLs or 
 T cells), CD3 CD4 CD8
(T helper/memory), and CD3 CD4 CD8 (NK) cells (38,
40–43). Subsequently, the cells were fixed and stained for intracel-
lular IFN-
 and gated for their respective activated (IFN-
) phe-
notype. Compared to those in WT virus-infected pigs, the fre-
quencies of total CTLs/
 T cells in vR129A- and vRR129AA-
infected pigs were increased (but not statistically significantly) at
21 dpi and then reduced significantly at 35 dpi (Fig. 9A), while the
frequencies of activated (IFN-
) CTLs/
 T cells in the same
mutant-infected pigs were increased at 7 dpi and then decreased at
35 dpi (but not statistically significantly) (Fig. 9B). In compari-
sons of WT virus-infected pigs with vR129A- and vRR129AA-
infected pigs, a trend of frequency changes similar to that of
CTLs/
 T cells was observed in total and activated T helper/
memory cells from pigs at all three days postinfection (Fig. 9C and
D). The frequency of NK cells was significantly increased only in
vRR129AA-infected pigs at 7 dpi (Fig. 9E). These data suggest that
NK cells and the two important T cell subsets were activated par-
ticularly in PRRSV vRR129AA mutant-infected pigs, suggesting
virus-specific activation of innate and adaptive immunity.
DISCUSSION
Many studies have demonstrated that a potent innate immune
response induced by microbial infection/vaccination will lead to
the generation of sufficient adaptive immunity, which subse-
quently clears pathogen infection from the host completely (44,
45). However, PRRSV infection generally induces poor antiviral
innate IFN and cytokine responses, which result in weak adaptive
immunity (46–50). One of the key steps in new PRRS vaccine
construction is to develop strategies to target these initial immune
response events to enhance virus-specific immunity. Previous
studies of other viral pathogens showed that recombinant viruses
generated with targeted mutations (deletions) in genes encoding
immune antagonists are excellent candidates for modified live-
virus (MLV) vaccines (51–54). The (selected) recombinant vi-
FIG 8 Comparison of IFN-
 production levels in pigs inoculated with the WT virus and nsp1 mutants. Pigs were uninfected (mock) or infected with WT
PRRSV (WT) or the three indicated mutants (vR128A, vR129A, and vRR129AA). Blood samples were collected on the indicated days postinfection, and BALF
and lung lysates were prepared by using lungs harvested on the day of necropsy (7, 21, and 35 dpi). IFN-
 levels in serum (A) and lung lysates (B) and IL-6 levels
in BALF (C) and lung lysates (D) were analyzed by an ELISA. Each data point represents the mean value  SEM of data from 3 pigs. Statistical significance
between the wild-type virus-infected group and mutant virus-infected groups was determined by one-way ANOVA and Tukey’s test and is indicated with
asterisks (*, P 0.05; **, P 0.01).
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ruses normally grow well in tissue culture, while in infected ani-
mals, they are attenuated but still replicate to sufficient amounts
for stimulating robust immune responses. Several PRRSV pro-
teins have been identified as antagonists of type I IFN induction
(and signaling), and nsp1 was determined to have the strongest
inhibitory effect among these proteins (22–24, 26). Therefore, in
this study, our vaccine development strategy is to generate recom-
binant viruses with targeted mutations in the nsp1 regions.
Our previous study identified a highly conserved GKYLQ
RRLQmotif in nsp1 that is critical for its inhibitory effect on type
I IFN production and signaling. Based on the crystal structure of
nsp1, three basic residues (K124, R128, and R129) in the GKYL
QRRLQ motif (boldface type indicates the positions of the three
basic residues) are exposed on the surface of the protein. In our
previous study, the K124A/R128A double mutation impaired the
IFN antagonist function of nsp1 (26). In this study, we further
tested each of these three individual residues. In comparison to
WT nsp1, nsp1mutants carrying alanine substitutions at R128
and R129 showed a significantly reduced antagonism effect on
reporter gene expression under the control of the IFN- promoter
(p125-Luc); however, the K124A mutant still had an inhibitory
effect on reporter gene expression similar to that of WT nsp1.
Similar results were observed in a luciferase reporter assay
(pISRE-Luc) utilized to examine the inhibitory effect on type I
IFN signaling. Both WT nsp1 and the K124A mutant severely
suppressed luciferase reporter expression, in contrast to the sig-
nificantly higher levels of luciferase expression in cells transfected
with nsp1mutants that contain mutations at R128 and/or R129
(Fig. 1B). These results indicate that the R128 and R129 residues,
but not K124, are critical for nsp1’s function in antagonizing
type I IFN production and signaling.
As we discussed previously (26), suppression of host cellular
gene expression, including nsp1 self-expression, could be a
mechanism of its immune antagonist function. An obviously
higher level of nsp1 expression was detected for the R128A and
K124A/R128A (1KO) mutants than for theWT byWestern blot
analysis (Fig. 1C). Interestingly, the combination of the R129A
and R128A substitutions (RR129AA) appeared to restore the abil-
ity of nsp1 to suppress its self-expression. The single alanine
substitution at residue R129 did not impair the ability of nsp1 to
suppress its self-expression, although it attenuated the ability of
nsp1 to suppress type I IFN expression. These data make us
speculate that different mechanisms may be utilized by the R128
and R129 residues to evade host innate immune defense, which
needs to be further elucidated.
As discussed above, besides its function as an innate immune
antagonist, nsp1 was recently identified as a transactivator for
the expression of the 2/1 PRF products nsp2TF and nsp2N.
Both nsp2TF and nsp2N share the N-terminal two-thirds se-
quence of nsp2, which contains the PLP2 domain. PLP2 was also
identified as an innate immune antagonist that is capable of re-
moving ubiquitin (Ub) and Ub-like modifiers like ISG15 from
host cell substrates (55–58). In testing the effect of nsp1 during
viral infection (see below), it remains to be established to what
extent nsp1 directly modulates the innate immune response or
whether it does so by stimulating the expression of nsp2TF and
nsp2N.
In this study, we generated recombinant viruses of nsp1mu-
tants using a reverse-genetics approach, including vK124A,
vR128A, vR129A, and vRR129AA. For comparison, our previ-
ously constructed mutant, v1KO (containing the K124A/R128A
double mutation), was included for characterization of virus
growth in cell culture. In comparison to the WT virus, all nsp1
mutants except vK124A had attenuated growth ability in cell cul-
ture, but their peak viral titers all reached 5 log TCID50/ml,
which is acceptable for subsequent application in animals. Multi-
ple-step virus growth curves showed that vR128A and vR129Ahad
slightly slower growth kinetics, while v1KO and vRR129AA
showed1- to 1.5-log-lower virus titers than that of the parental
virus at all tested time points (Fig. 3A). It is worth noting that
v1KO, containing the K124A/R128A double mutation, had a
lower virus titer than that of the mutant virus with the single
R128A mutation, but the single K124A mutation did not have
much of an effect on virus growth ability in cell culture. In addi-
tion, none of the mutations affected the release of nsp1 from the
nsp1-2 polyprotein (Fig. 2B), suggesting that the reduced growth
rate (viral titer) of the nsp1mutants may not be directly caused
by a basic defect in replicase polyprotein proteolysis.We speculate
FIG 9 T helper and memory T cell responses in pigs infected with nsp1
mutants. PBMCs collected at 7, 21, and 35 dpi were unstimulated or restimu-
lated with the respective WT or mutant viruses that were used to infect pigs.
Cells were immunostained using the pig-specific markers CD3, CD4, and
CD8, followed by intracellular IFN-
 detection. Each lymphocyte subset was
grouped based on the combination of cellular markers: CD3 CD4 CD8
(CTLs/
 T cells) (A), CD3 CD4 CD8 IFN-
 (activated CTLs/
 T
cells) (B), CD3 CD4 CD8 (T helper/memory cells) (C), CD3 CD4
CD8 IFN-
 (activated T helper/memory cells) (D), and CD3 CD8
IFN-
 (activated NK cells) (E). A key explaining the treatment groups in
panels A, B, D, and E is given in panel C. Each bar is the mean value SEM of
data from 3 pigs. Statistical significance between wild-type and mutant virus-
infected pig groups was determined by one-way ANOVA followed by Tukey’s
t test and is indicated with an asterisk (*, P 0.05).
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that R128A, R129A, or the combined K124A/R128A or R128A/
R129Amutationmay change the nsp1 protein or RNA structure,
which in turn affects virus replication ability. The in-depthmech-
anism of these mutations that affect virus growth ability requires
more studies in the future.When tested with the vaccinia virus-T7
expression system, the expression of nsp2TF was impaired by al-
anine substitutions at residues 128 and 129 using nsp1-2 expres-
sion constructs (Fig. 2A). Under virus infection conditions, these
two residues are also essential for the PRF transactivator function
of nsp1 (data not shown). Taken together, our data indicate that
the three basic amino acids exposed on the nsp1 surface appear
to have different functions, and the detailed mechanism needs to
be further elucidated.
Subsequently, these mutants were characterized in nursery
pigs. Since the K124A mutant did not have much of an effect on
the innate suppression function of nsp1, and the recombinant
virus containing the K124A mutation did not have much of an
effect on virus replication, thismutant was excluded in the present
animal study. In a previous study, we evaluated 1KO and WT
viruses in pigs. 1KO showed an overattenuated phenotype, with
virus growing to an extremely low titer (5 104 RNA copies/ml
in serum), which is 2 to 3 logs lower than that of the wild-type
virus. As a consequence, pigs did not seroconvert until 28 dpi. The
initial IFN- response was very limited (8.4 pg/ml serum at 3 dpi);
in contrast, we detected an IFN- response (100.9 pg/ml serum at
3 dpi) in WT virus-infected pigs. As discussed above, a single
mutation at the K124 residue did not seem to have much of an
effect on the in vitro growth ability of the virus, but combined
mutations at R128 significantly impaired the virus growth ability
in vitro and in vivo. The in-depth mechanism of the involvement
of K124 in viral replication and its function in relation to the
combined effect of the R128 mutation need to be further studied.
Since our previous data showed an overattenuated phenotype of
1KO, in the present study, we focused on characterizing the
other three nsp1mutants (vR128A, vR129A, and vRR129AA) in
nursery pigs. Active virus replication was observed in all of the
virus-infected pigs. The viremia data indicate that, consistent with
in vitro results, nsp1mutants were also attenuated in pigs. At all
time points, vR128A- and vRR129AA-infected pigs had consis-
tently lower mean viral RNA loads and infectious virus titers than
didWTvirus-infected pigs. The pigs in the vR129A group also had
lower levels of viremia than that of the WT virus group at early
time points; however, they showed even higher levels of viremia
than that of the WT group at 35 dpi. These results suggest that
vR129A could be reversed back to the WT virus. Subsequently,
sequence analysis of the nsp1 coding region was performed to
confirm the stability of themutations introduced into the virus. In
viruses recovered at 21 dpi, the designed alanine substitutions
were stably maintained, except for a reversion identified in one of
the pigs (pig 31) infected with vR129A. We further sequenced the
nsp1 coding region in the viruses recovered from vR129A-in-
fected pigs at 14 dpi, and the results showed that reversion oc-
curred only in pig 31 and not the other five tested pigs. Unexpect-
edly, no reversion in the nsp1 coding region was identified in the
vR129A group of pigs at 35 dpi, although the vR129A group of
pigs showed even higher virus titers than those of theWT group of
pigs. We speculate that spontaneous mutations in other regions
of the virus genomemay compensate for the viral replication abil-
ity in vivo. Remarkably, for the viruses that stably maintained the
designed mutations, vR128A and vR129A, in infected pigs, a spe-
cific second-site mutation of Ser122 to Pro122 was consistently
identified. We analyzed the sequence of nsp1 from in vitro ex-
pression plasmids and original recombinant viruses that grew in
MARC-145 cells (before inoculation into pigs), and the results
showed that Ser122 was stablymaintained in vR128A, vR129A, and
vRR129AA. The data suggest that Pro122 may contribute to virus
fitness in vivo and that the Ser122-to-Pro122 substitutionmay com-
promise the side effect of our designed mutations on virus repli-
cation ability in animals. Whether the Ser122-to-Pro122 substitu-
tion has an effect on the function of nsp1 needs to be further
studied.
Given the impaired ability of the vR128A, vR129A, and
vRR129AAmutants to antagonize the innate immune response in
vitro, we further assessed the ability of these viruses to induce a
host immune response in vivo. After immunization, no clinical
symptoms and adverse side effects were observed in the WT and
mutant virus-infected pigs. In addition, when three pigs per group
were terminated at 7, 21, and 35 dpi, no obvious lung lesions were
observed. This result is expected, since the WT virus SD95-21
(backbone of nsp1 mutants) has 99.5% nucleotide identity to
VR2332, the parental virus of the PRRS MLV vaccine (Ingelvac
PRRS MLV; Boehringer Ingelheim Vetmedica Inc.), and 99.6%
identity to Ingelvac PRRS MLV. In addition, SD95-21 virus was
adapted to grow in MARC-145 cells. In previous studies, pigs in-
fected with PRRSMLV of the VR2332 strain showed very mild or
undetectable clinical symptoms, gross lesions, or histopathologi-
cal lesions (59). The goal of our vaccine development strategy is to
improve the ability of current MLV vaccines to stimulate higher-
level innate and cell-mediated immune responses.
Since type I IFNs are the principal cytokines for innate immu-
nity against viral infections, IFN-was selected as a representative
to assess the ability of PRRSV to induce the host innate immune
response. Consistent with our data generated in an in vitro expres-
sion system, nsp1 mutants induced higher levels of IFN- than
did theWTvirus at early time points postinfection. In comparison
to WT virus-infected pigs, high cytotoxic activity of NK cells was
also observed in pigs infected with nsp1 mutants. These results
suggest that PRRSV nsp1 plays a crucial role in suppressing host
innate immunity, andmodifying this protein could effectively im-
prove the ability of PRRSV to stimulate the host innate immune
response. Furthermore, these mutants induced earlier and
higher-level IFN-
 expression than did the WT virus. As an
important factor in adaptive immunity against viral infection,
IFN-
 increases antigen presentation and promotes Th1 cell
differentiation (60). The increased expression of IFN-
 in mu-
tant virus-infected pigs indirectly indicates the activation of the
Th1 cell-mediated immune response. This not only was observed
in serum of mutant-infected pigs but also was indicated by the
increased activation of CTLs/
 T cells, T helper/memory cells,
and NK cells. Previously, an increased frequency of activated T
helper/memory cells in pigs was shown to be beneficial in the
clearance of Aujeszky’s disease virus, African swine fever virus,
classical swine fever virus, and PRRSV infections (33, 41, 61–64).
Taken together, besides the induction of higher-level innate im-
mune responses, these mutants may also have a stronger ability to
augment Th1 cell-mediated adaptive immunity than the WT vi-
rus. As a candidate vaccine, one would expect its ability to stimu-
late a significant humoral response in animals. In fact, we per-
formed both a virus-neutralizing antibody assay and an ELISA
using serum samples, but the results showed no significant differ-
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ence among pig groups infected with the WT virus and the three
nsp1mutants (data not shown). It is a well-established phenom-
enon that a strong Th1 response suppresses the Th2 response (hu-
moral response) and vice versa, which was demonstrated previ-
ously in mice (65, 66) and pigs (33, 64, 67). Therefore, our data
suggest that the lack of an improved virus-neutralizing antibody
response in nsp1mutant-infected pigs could be partially caused
by the strong Th1 response. Future virus challenge studies of
nsp1 mutant-vaccinated pigs may reveal benefits of increased
Th1 responses in virus clearance.
Based on our data, the vRR129AAmutant could be a potential
vaccine candidate, and this attenuation strategy could be easily
applied to improve current vaccines. This conclusion is based on
multiple observations. First, vRR129AA can grow to sufficient vi-
rus titers in cell culture (5 log TCID50/ml), which facilitates
large-scale vaccine production. Second, in comparison to theWT
virus, vRR129AA induced an early and strong innate immune
response, whichwas supported by elevated levels of IFN- expres-
sion and NK cell cytotoxic activity. The improved innate immune
response appears to augment cell-mediated adaptive immunity,
indicated by the early induction of IFN-
 expression by both NK
cells and T cells, followed by the depletion of activated T cell sub-
sets, as presented in phenotypic analyses of PBMCs. Another im-
portant aspect is that this mutant appeared to be quickly cleared
from virus-infected pigs and showed better genetic stability than
nsp1 mutants containing a single alanine substitution (vR128A
and vR129A). Nevertheless, the protection efficacy of this poten-
tial vaccine candidate needs to be further assessed in animal chal-
lenge studies. Finally, residues R128 and R129 are highly con-
served in all available PRRSV strains, as described previously (25,
26); therefore, the technology described in this study can be easily
applied to current commercial vaccines and other candidate vac-
cines.
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